MyFinsight
Home
Blog
About
Back
Income Statement
Barinthus Biotherapeutics plc. (BRNS)
Barinthus Biotherapeutics plc. (BRNS)
source: myfinsight.com
Net loss
attributable to barinthus...
-$10,580,000
(49.91%↑ Y/Y)
Net loss
attributable to...
-$19,000
(-850.00%↓ Y/Y)
Net loss
-$10,599,000
(49.83%↑ Y/Y)
Tax benefit
-$23,000
(8.00%↑ Y/Y)
Interest income
$343,000
(-34.42%↓ Y/Y)
Research and development
incentives
$42,000
(-96.87%↓ Y/Y)
Other income
$26,000
(-91.88%↓ Y/Y)
Loss before income
tax
-$10,622,000
(49.78%↑ Y/Y)
Total other income,
net
$397,000
(-81.73%↓ Y/Y)
Interest expense
$14,000
(16.67%↑ Y/Y)
Loss from operations
-$11,019,000
(52.76%↑ Y/Y)
Other operating
income
$5,000
(-61.54%↓ Y/Y)
Total operating
expenses
$11,024,000
(-52.76%↓ Y/Y)
General and
administrative
$7,101,000
(-53.84%↓ Y/Y)
Research and development
$3,923,000
(-50.67%↓ Y/Y)
Back